Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI.
Masaaki NakaseDaijiro TomiiDik HegFabien PrazStefan StorteckyJonas LanzDavid ReinekeStephan WindeckerThomas PilgrimPublished in: European heart journal. Quality of care & clinical outcomes (2023)
Patients with LFLG-pEF AS and AF experienced no relevant recovery of stroke volume after TAVI, but a more than two-fold increased risk of death compared to patients with HG AS or LFLG-pEF AS without AF. Clinical Trial Registration: https://www.clinicaltrials.gov. NCT01368250.
Keyphrases
- aortic stenosis
- ejection fraction
- atrial fibrillation
- transcatheter aortic valve implantation
- aortic valve replacement
- transcatheter aortic valve replacement
- aortic valve
- clinical trial
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- left ventricular
- direct oral anticoagulants
- heart failure
- coronary artery disease
- open label
- venous thromboembolism
- phase ii
- aqueous solution